Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate vs esketamine gargle for prevention of postoperative sore throat after laryngeal mask airway ventilation
ChiCTR2500107480Phase 4Not yet recruiting
- Sponsor
- General Hospital of Ningxia Medical University
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Post-extubation sore throat (POST) comparing Magnesium sulfate gargle with Esketamine gargle (2 arms). Primary endpoint: Postoperative sore throat. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
magnesium sulfateesketamine
03
Conditions
Post-extubation sore throat (POST)
Beyond the preview
Go deeper on ChiCTR2500107480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107480.